Wednesday, July 8, 2026

pharma · Rheumatoid Arthritis · Calcium

Universal Integrated

Universal Corporation is a pharma organization headquartered in HILLSIDE, NJ, CN. Primary therapeutic focus areas include Rheumatoid Arthritis, Calcium, Polycystic Ovary Syndrome, Diabetic Foot, Plaque Psoriasis. NovaPha

HILLSIDE, NJ, CN HQ
2006 Founded
304 Employees
NMPA registrant Type
Company details
Status
Public
HQ
HILLSIDE, NJ, CN
Founded
2006
Employees
304
Programs
89
Drugs
105
Patents
42
Clinical program

PEG-Interferon a-2b + Ribavirin

Phase 3 · small molecule · Chronic Hepatitis C Infection in HIV-Infected Persons

PEG-Interferon a-2b + Ribavirin for Chronic Hepatitis C Infection in HIV-Infected Persons is a Phase 3 program (small_molecule) at Universal Integrated with 1 ClinicalTrials.gov record(s).

← All Universal Integrated projects Phase 3 small molecule completed

Internal code HRN 005

Full intelligence profile for this program is being prepared.

At a glance

Sponsor
Universal Integrated
Phase
Phase 3
Modality
small_molecule
Indication
Chronic Hepatitis C Infection in HIV-Infected Persons
Status
completed
Trials
1